Suchergebnisse - "2494G1JF75"

PubPharm (2.348)

41

Causes of HIV Treatment Interruption during the Last 20 Years : A Multi-Cohort Real-Life Study

enthalten in: Viruses | 2023

von De Vito, A. | Ricci, E. | Menzaghi, B. | +18

42

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Skalafouris, C. | Samer, C. | Stirnemann, J. | +6

43

The investigation of the complex population-drug-drug interaction between ritonavir-boosted lopinavir and chloroquine or ivermectin using physiologically-based pharmacokinetic modeling

enthalten in: Drug metabolism and personalized therapy | 2023

von Alsmadi, M.

44

Impact of Drug Exposure on Resistance Selection Following Artemether-Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda

enthalten in: Clinical pharmacology and therapeutics | 2023

von Kay, K. | Goodwin, J. | Ehrlich, H. | +13

45

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19 : a randomized clinical trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Kaizer, A. | Shapiro, N. | Wild, J. | +13

46

COVID-19 : a wreak havoc across the globe

enthalten in: Archives of physiology and biochemistry | 2023

von Rehman, H. | Ahmad, M.

47

Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France : Results of the PHARMA-COVID study

enthalten in: PloS one | 2023

von Peretti, M. | Rebaudet, S. | Chiche, L. | +2

48

Co-administration of rimonabant prevents glucose intolerance in Sprague-Dawley rats treated chronically with lopinavir/ritonavir and zidovudine : an experimental study design

enthalten in: The Pan African medical journal | 2023

von Makamu, B. | Mwangi, P. | Bukachi, F.

49

Lopinavir-Loaded Self-Nanoemulsifying Drug Delivery System for Enhanced Solubility : Development, Characterisation and Caco-2 Cell Uptake

enthalten in: Current drug delivery | 2023

von Khan, A. | Akhtar, S. | Yadav, Y. | +4

50

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

enthalten in: JAMA | 2023

von Writing Committee for the REMAP-CAP Investigators | Higgins, A. | Berry, L. | +164

CommentIn: JAMA. 2023 Jan 3;329(1):25-27. - PMID 36525259